CPHI - China Pharma Holdings, Inc. Company Cash Volume

Public company logo of China Pharma Holdings (CPHI)

The cash liquidity metric demonstrates a steady cash flow, where the 0.00 mark serves as a key figure for China Pharma Holdings (CPHI). Stable cash supports the mature prescription drug segment. Revenues are based on a wide range of antibiotics and government contracts in the PRC. Additionally, amortized generics for CNS therapy, which require no new R&D expenditures, generate capital.

chinapharmaholdings.com - CPHI Company Cash Balance (period 07/04/2022 - 11/21/2026)

Financial and market metric breakdowns for China Pharma Holdings (CPHI)

- stock value and consensus price forecast:
Comprehensive company analysis:CPHI China Pharma Holdings
Brand item of China Pharma

This indicator tracks the volume of highly liquid assets available for immediate use. Analyzing this metric allows for an assessment of the issuer's solvency and its resilience to market volatility. The trend in the company's cash position reflects the balance between financial security and capital efficiency. For China Pharma Holdings (CPHI), such reserves are critical when implementing robotic screening systems. Sufficient liquidity ensures the seamless deployment of software robots for processing clinical trial data.